- The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
-
Hashimoto
- Clin Psychopharmacol Neurosci.
- 2014 Apr;12(1):72-73.
No abstract available.
- A Case of Aripiprazole Induced Tardive Dyskinesia in a Neuroleptic-Naive Patient with Two Years of Follow Up
-
Goyal R, Devi SH
- Clin Psychopharmacol Neurosci.
- 2014 Apr;12(1):69-71.
Tardive dyskinesia (TD) is arguably the most serious and potential irreversible side effect of antipsychotic medication. Traditionally first generation antipsychotics are the neuroleptics considered to have higher risk of TD...
- A Case of Acute Pancreatitis Associated with Risperidone Treatment
-
Kawabe K, Ueno SI
- Clin Psychopharmacol Neurosci.
- 2014 Apr;12(1):67-68.
Acute pancreatitis with antipsychotic treatment is rare but sometimes causes a fatal adverse effect. Most cases of acute pancreatitis due to atypical antipsychotic agents are reported to occur within six...
- Successful Treatment of Anorexia Nervosa in a 10-year-old Boy with Risperidone Long-acting Injection
-
Umehara H, Iga J, Ohmori T
- Clin Psychopharmacol Neurosci.
- 2014 Apr;12(1):65-66.
Although the effectiveness of medication in the treatment of anorexia nervosa is uncertain, atypical antipsychotics such as olanzapine and risperidone have been used empirically for decades. we describe the case...
- A Pilot Study for Discovering Candidate Genes of Chromosome 18q21 in Methamphetamine Abusers: Case-control Association Study
-
Lee BD, Park JM, Lee YM, Moon ES, Jeong HJ, Chung YI, Rim HD
- Clin Psychopharmacol Neurosci.
- 2014 Apr;12(1):54-64.
OBJECTIVE: It was previously suggested that the malic enzyme 2 (ME2) as the candidate gene for psychosis in fine mapping of chromosome 18q21. Chromosome 18q21 is also one of the...
- Drug Treated Schizophrenia, Schizoaffective and Bipolar Disorder Patients Evaluated by qEEG Absolute Spectral Power and Mean Frequency Analysis
-
Wix-Ramos , Moreno X, Capote E, Gonzalez G, Uribe E, Eblen-Zajjur A
- Clin Psychopharmacol Neurosci.
- 2014 Apr;12(1):48-53.
OBJECTIVE: Research of electroencephalograph (EEG) power spectrum and mean frequency has shown inconsistent results in patients with schizophrenic, schizoaffective and bipolar disorders during medication when compared to normal subjects thus;...
- Comparison of Memory Function and MMPI-2 Profile between Post-traumatic Stress Disorder and Adjustment Disorder after a Traffic Accident
-
Bae SM, Hyun MH, Lee SH
- Clin Psychopharmacol Neurosci.
- 2014 Apr;12(1):41-47.
OBJECTIVE: Differential diagnosis between post-traumatic stress disorder (PTSD) and adjustment disorder (AD) is rather difficult, but very important to the assignment of appropriate treatment and prognosis. This study investigated methods...
- Duloxetine, a Selective Noradrenaline Reuptake Inhibitor, Increased Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol but Not Homovanillic Acid in Patients with Major Depressive Disorder
-
Atake K, Yoshimura , Hori H, Katsuki A, Ikenouchi-Sugita A, Umene-Nakano W, Nakamura J
- Clin Psychopharmacol Neurosci.
- 2014 Apr;12(1):37-40.
OBJECTIVE: We investigated the effects of duloxetine on the plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor (BDNF) in 64 patients with major depressive disorder (MDD). METHODS: Major depressive...
- Effects of Brilliant Blue G on Serum Tumor Necrosis Factor-alpha Levels and Depression-like Behavior in Mice after Lipopolysaccharide Administration
-
Ma M, Ren Q, Zhang JC, Hashimoto
- Clin Psychopharmacol Neurosci.
- 2014 Apr;12(1):31-36.
OBJECTIVE: Accumulating evidence suggests that inflammation plays a role in the pathophysiology of major depression. The adenosine triphosphate (ATP)-sensitive P2X7 receptor (P2X7R) plays a crucial role in microglial activation caused...
- Advanced Pharmacotherapy Evidenced by Pathogenesis of Autism Spectrum Disorder
-
Lee YJ, Oh SH, Park C, Hong M, Lee AR, Yoo HJ, Shin CY, Cheon KA, Bahn GH
- Clin Psychopharmacol Neurosci.
- 2014 Apr;12(1):19-30.
In clinical practice, pharmacological treatment is mostly focused on behavioral symptoms in everyday life. Nevertheless, persistent effort continues to develop medication for causal treatment. Recent changes in diagnostic criteria from...
- Neuroimmunological Aberrations and Cerebral Asymmetry Abnormalities in Schizophrenia: Select Perspectives on Pathogenesis
-
Venkatasubramanian G, Debnath M
- Clin Psychopharmacol Neurosci.
- 2014 Apr;12(1):8-18.
Within the wide-ranging gamut of factors that comprise gene-environment interactions postulated to underlie schizophrenia, the crosstalk between environmental factors and feto-maternal immune components has been put forth as one of...
- Strategies for Early Non-response to Antipsychotic Drugs in the Treatment of Acute-phase Schizophrenia
-
Hatta K, Ito H
- Clin Psychopharmacol Neurosci.
- 2014 Apr;12(1):1-7.
As a strategy for antipsychotic treatment of schizophrenia, monotherapy is clearly optimal when both effective and tolerated. When a patient fails to respond to an adequate dose of an antipsychotic,...
